|
|
|
Volumn 8, Issue 1, 1997, Pages 67-78
|
|
New medicines in development for AIDS: 1996 survey from the pharmaceutical research and manufacturers of America
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B LIPID COMPLEX;
AMPRENAVIR;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
ATOVAQUONE;
AZITHROMYCIN;
BEHENYL ALCOHOL;
BEXAROTENE;
CYTOMEGALOVIRUS ANTIBODY;
DAUNORUBICIN;
FOMIVIRSEN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
GALLIUM CITRATE;
GALLIUM NITRATE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOMODULATING AGENT;
ITRACONAZOLE;
KYNOSTATIN 272;
PACLITAXEL;
PENTAMIDINE ISETHIONATE;
PIRITREXIM;
PROTEINASE INHIBITOR;
RIFABUTIN;
RIFALAZIL;
TERBINAFINE;
TRECOVIRSEN;
UNINDEXED DRUG;
VORICONAZOLE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AIDS RELATED COMPLEX;
ANOREXIA;
BIOTECHNOLOGY;
CACHEXIA;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
GENE THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KAPOSI SARCOMA;
LYMPHOMA;
REVIEW;
ANTI-HIV AGENTS;
DRUG APPROVAL;
DRUG INDUSTRY;
HIV INFECTIONS;
HUMANS;
TIME FACTORS;
|
|
EID: 0031004179
PISSN: 10455418
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|